Seeking Alpha

AGEN
Agenus

5/27/2012, 2:45 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
AGEN Market Currents more »
  • October 18, 2011 Agenus (AGEN +50%) skyrockets after the company reports a Phase 3 trial of GlaxoSmithKline's (GSK) malaria vaccine, which contains an Agenus drug agent, found the vaccine delivered positive results. Agenus is entitled to milestone payments for the vaccine, as well as "royalties for 10 years after commercial launch." [Healthcare, On the Move]
AGEN Cramer more »
Currently, there are no Cramer articles on AGEN.
AGEN Instablog posts more »
  • Agenus, Inc. (AGEN) Signs Agreement with NewVac to License, Develop and Market Agenus’ Kidney Cancer Vaccine in Russia
    Wed, Dec 21, 2011 QualityStocks Comment!
  • Agenus Inc. (AGEN) Announces Presentation of New Phase 2 Trial Data on Glioma Vaccine
    Thu, May 19, 2011 QualityStocks Comment!
  • Antigenics Inc. (AGEN) Video Chart for Friday, November 5, 2010
    Fri, Nov 5, 2010 QualityStocks Comment!
  • GRHU, LKQX, AGEN, ORCH - Weekend Review For CRWEPicks.com
    Sun, Oct 31, 2010 crwepicks Comment!
  • Daily Updates from AndrewNava.com - May 5, 2010
    Wed, May 5, 2010 Andrew Nava Comment!
Write a post on AGEN
AGEN StockTalks
AGEN vs. ETF Alternatives
Company Description

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates... More

Sector: Healthcare
Industry: Biotechnology
Country: United States